STOCK TITAN

[Form 4] Cohen & Steers Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Adam M. Derechin, Chief Operating Officer and Executive Vice President of Cohen & Steers, Inc. (CNS), reported an acquisition on 08/21/2025 of 189 dividend-equivalent restricted stock units related to the company’s third-quarter 2025 dividend. The units accrued to Mr. Derechin on previously granted unvested restricted stock units from January 2022, 2023, 2024 and 2025. The Form 4 shows the acquisition price as $0 and indicates 528,676 shares beneficially owned by the reporting person following the transaction. The filing was signed by an attorney-in-fact on 08/22/2025.

Adam M. Derechin, Chief Operating Officer ed Executive Vice President di Cohen & Steers, Inc. (CNS), ha comunicato l'acquisizione, avvenuta il 21/08/2025, di 189 unità di azioni ristrette equivalenti al dividendo relative al dividendo del terzo trimestre 2025 della società. Tali unità si sono accumulate in relazione a unità di azioni ristrette non ancora maturate precedentemente assegnate nei gennaio 2022, 2023, 2024 e 2025. Il Form 4 indica un prezzo di acquisizione pari a $0 e riporta che, a seguito dell'operazione, la persona che ha effettuato la segnalazione detiene beneficiariamente 528.676 azioni. Il documento è stato firmato da un procuratore il 22/08/2025.

Adam M. Derechin, Chief Operating Officer y Executive Vice President de Cohen & Steers, Inc. (CNS), informó la adquisición, el 21/08/2025, de 189 unidades restringidas equivalentes a dividendos relacionadas con el dividendo del tercer trimestre de 2025 de la compañía. Estas unidades se acumularon sobre unidades restringidas no devengadas previamente otorgadas en enero de 2022, 2023, 2024 y 2025. El Formulario 4 muestra un precio de adquisición de $0 e indica que, tras la transacción, la persona informante posee beneficiariamente 528.676 acciones. La presentación fue firmada por un apoderado el 22/08/2025.

Adam M. Derechin은(는) Cohen & Steers, Inc.(CNS)의 최고운영책임자이자 부사장으로서 2025-08-21에 회사의 2025년 3분기 배당과 관련된 배당 상당 제한주식 단위 189주를 취득했다고 신고했습니다. 이 단위들은 2022년, 2023년, 2024년 및 2025년 1월에 이전에 부여된 미확정(미수여) 제한주식 단위에 대해 발생한 것입니다. Form 4에는 취득 가격이 $0로 기재되어 있으며, 거래 후 보고인은 528,676주를 실질적으로 보유하게 된 것으로 나타납니다. 서류는 2025-08-22에 대리인이 서명했습니다.

Adam M. Derechin, Chief Operating Officer et Executive Vice President de Cohen & Steers, Inc. (CNS), a déclaré l'acquisition, le 21/08/2025, de 189 unités d'actions restreintes équivalentes au dividende liées au dividende du troisième trimestre 2025 de la société. Ces unités se sont accumulées sur des unités d'actions restreintes non acquises antérieurement attribuées en janvier 2022, 2023, 2024 et 2025. Le formulaire 4 indique un prix d'acquisition de 0 $ et précise qu'après la transaction la personne déclarante détient à titre bénéficiaire 528 676 actions. Le dépôt a été signé par un mandataire le 22/08/2025.

Adam M. Derechin, Chief Operating Officer und Executive Vice President von Cohen & Steers, Inc. (CNS), meldete den Erwerb von 189 dividendenäquivalenten Restricted Stock Units am 21.08.2025, die sich auf die Dividende des dritten Quartals 2025 der Gesellschaft beziehen. Die Einheiten ergaben sich aus zuvor gewährten, noch nicht unverfallbaren Restricted Stock Units aus Januar 2022, 2023, 2024 und 2025. Das Formular 4 weist einen Erwerbspreis von $0 aus und gibt an, dass die meldende Person nach der Transaktion wirtschaftlich 528.676 Aktien besitzt. Die Einreichung wurde am 22.08.2025 von einem Bevollmächtigten unterzeichnet.

Positive
  • Timely and compliant disclosure of an insider compensation-related transaction under Section 16
  • Clarity on nature of acquisition: dividend-equivalent RSUs credited to previously granted unvested RSUs
Negative
  • None.

Insights

TL;DR: Routine insider reporting of dividend-equivalent units; reflects compensation mechanics, not an open-market trade.

This Form 4 documents a non-cash acquisition of dividend-equivalent restricted stock units tied to previously granted unvested RSUs. Such entries are typically administrative and relate to compensation or dividend accruals rather than discretionary purchases or sales. The disclosure satisfies Section 16 reporting for an executive officer and provides transparency on post-accrual beneficial ownership totaling 528,676 shares.

TL;DR: Compensation-related accrual reported; small incremental grant added to unvested RSUs from prior years.

The explanation clarifies these are dividend equivalents credited to existing unvested RSUs granted in January of 2022 through 2025. This is a common practice to preserve dividend value for holders of restricted units. The quantity—189 units—appears modest relative to the total reported beneficial ownership, indicating an administrative award rather than a material change in incentives or ownership position.

Adam M. Derechin, Chief Operating Officer ed Executive Vice President di Cohen & Steers, Inc. (CNS), ha comunicato l'acquisizione, avvenuta il 21/08/2025, di 189 unità di azioni ristrette equivalenti al dividendo relative al dividendo del terzo trimestre 2025 della società. Tali unità si sono accumulate in relazione a unità di azioni ristrette non ancora maturate precedentemente assegnate nei gennaio 2022, 2023, 2024 e 2025. Il Form 4 indica un prezzo di acquisizione pari a $0 e riporta che, a seguito dell'operazione, la persona che ha effettuato la segnalazione detiene beneficiariamente 528.676 azioni. Il documento è stato firmato da un procuratore il 22/08/2025.

Adam M. Derechin, Chief Operating Officer y Executive Vice President de Cohen & Steers, Inc. (CNS), informó la adquisición, el 21/08/2025, de 189 unidades restringidas equivalentes a dividendos relacionadas con el dividendo del tercer trimestre de 2025 de la compañía. Estas unidades se acumularon sobre unidades restringidas no devengadas previamente otorgadas en enero de 2022, 2023, 2024 y 2025. El Formulario 4 muestra un precio de adquisición de $0 e indica que, tras la transacción, la persona informante posee beneficiariamente 528.676 acciones. La presentación fue firmada por un apoderado el 22/08/2025.

Adam M. Derechin은(는) Cohen & Steers, Inc.(CNS)의 최고운영책임자이자 부사장으로서 2025-08-21에 회사의 2025년 3분기 배당과 관련된 배당 상당 제한주식 단위 189주를 취득했다고 신고했습니다. 이 단위들은 2022년, 2023년, 2024년 및 2025년 1월에 이전에 부여된 미확정(미수여) 제한주식 단위에 대해 발생한 것입니다. Form 4에는 취득 가격이 $0로 기재되어 있으며, 거래 후 보고인은 528,676주를 실질적으로 보유하게 된 것으로 나타납니다. 서류는 2025-08-22에 대리인이 서명했습니다.

Adam M. Derechin, Chief Operating Officer et Executive Vice President de Cohen & Steers, Inc. (CNS), a déclaré l'acquisition, le 21/08/2025, de 189 unités d'actions restreintes équivalentes au dividende liées au dividende du troisième trimestre 2025 de la société. Ces unités se sont accumulées sur des unités d'actions restreintes non acquises antérieurement attribuées en janvier 2022, 2023, 2024 et 2025. Le formulaire 4 indique un prix d'acquisition de 0 $ et précise qu'après la transaction la personne déclarante détient à titre bénéficiaire 528 676 actions. Le dépôt a été signé par un mandataire le 22/08/2025.

Adam M. Derechin, Chief Operating Officer und Executive Vice President von Cohen & Steers, Inc. (CNS), meldete den Erwerb von 189 dividendenäquivalenten Restricted Stock Units am 21.08.2025, die sich auf die Dividende des dritten Quartals 2025 der Gesellschaft beziehen. Die Einheiten ergaben sich aus zuvor gewährten, noch nicht unverfallbaren Restricted Stock Units aus Januar 2022, 2023, 2024 und 2025. Das Formular 4 weist einen Erwerbspreis von $0 aus und gibt an, dass die meldende Person nach der Transaktion wirtschaftlich 528.676 Aktien besitzt. Die Einreichung wurde am 22.08.2025 von einem Bevollmächtigten unterzeichnet.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
DERECHIN ADAM M

(Last) (First) (Middle)
1166 AVENUE OF THE AMERICAS

(Street)
NEW YORK NY 10036

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
COHEN & STEERS, INC. [ CNS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Operating Officer, EVP
3. Date of Earliest Transaction (Month/Day/Year)
08/21/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/21/2025 A 189(1) A $0 528,676 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents the acquisition of dividend equivalent restricted stock units in connection with the issuer's third quarter 2025 dividend and accrued to the reporting person on unvested restricted stock units granted in January 2022, January 2023, January 2024 and January 2025.
Remarks:
/s/ Brian W. Heller, Attorney-in-Fact 08/22/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction was reported on the Form 4 for Cohen & Steers (CNS)?

The Form 4 reports the acquisition of 189 dividend-equivalent restricted stock units on 08/21/2025 credited to unvested RSUs.

Who is the reporting person on this Form 4 for CNS?

The reporting person is Adam M. Derechin, Chief Operating Officer and Executive Vice President of Cohen & Steers.

How many shares does the reporting person beneficially own after the transaction?

The filing shows 528,676 shares beneficially owned following the reported transaction.

Was this a cash purchase or an administrative award?

This was an administrative award of dividend-equivalent RSUs credited at $0, not an open-market purchase.

What grants did the dividend-equivalent RSUs relate to?

The units accrued to unvested restricted stock units previously granted in January 2022, January 2023, January 2024 and January 2025.
Cohen & Steers Inc

NYSE:CNS

CNS Rankings

CNS Latest News

CNS Latest SEC Filings

CNS Stock Data

3.74B
27.43M
46.04%
60.35%
3.77%
Asset Management
Investment Advice
Link
United States
NEW YORK